AIMS: Risk stratification is often used to determine the need and priority for coronary angiography. We investigated the contemporary value of Framingham and SCORE risk models, individual risk factors, B-type natriuretic peptide and high-sensitivity C-reactive protein (hs-CRP) in the current era of intensive risk management. METHODS AND RESULTS: Coronary artery disease (CAD) was obstructive (>or=50% stenosis) in 328 of 539 patients referred for elective diagnostic coronary angiography (61%). Lower rates of smoking, more exercise and lower cholesterol were noted in those with angiographic CAD, compatible with risk factor modification in these patients. Framingham and SCORE were associated with CAD both in patients with and without prior cardiovascular disease (CVD). In multivariate analysis only age, male sex, diabetes, chest pain and prior CVD were independent predictors of CAD; odds ratio 1.74 per 10 years (95% confidence interval: 1.34-2.27), 5.48 (3.36-8.92), 2.57 (1.44-4.60), 1.69 (1.02-2.81) and 2.61 (1.65-4.12), respectively. Classification of disease was not improved by B-type natriuretic peptide or hs-CRP when added to conventional risk factors, although the latter seems to have value in patients without earlier CVD and low-density lipoprotein-cholesterol of less than 3.4 mmol/l; the adjusted odds ratio for hs-CRP >or=2 mg/l in this sub-group was 2.49 (1.12-5.51, P=0.024). CONCLUSION: Framingham and SCORE risk models can be used in clinical practice to predict angiographic coronary disease although risk factor modification limits the predictive value of smoking, blood pressure, lipid profiles and cardiac biomarkers.
AIMS: Risk stratification is often used to determine the need and priority for coronary angiography. We investigated the contemporary value of Framingham and SCORE risk models, individual risk factors, B-type natriuretic peptide and high-sensitivity C-reactive protein (hs-CRP) in the current era of intensive risk management. METHODS AND RESULTS:Coronary artery disease (CAD) was obstructive (>or=50% stenosis) in 328 of 539 patients referred for elective diagnostic coronary angiography (61%). Lower rates of smoking, more exercise and lower cholesterol were noted in those with angiographic CAD, compatible with risk factor modification in these patients. Framingham and SCORE were associated with CAD both in patients with and without prior cardiovascular disease (CVD). In multivariate analysis only age, male sex, diabetes, chest pain and prior CVD were independent predictors of CAD; odds ratio 1.74 per 10 years (95% confidence interval: 1.34-2.27), 5.48 (3.36-8.92), 2.57 (1.44-4.60), 1.69 (1.02-2.81) and 2.61 (1.65-4.12), respectively. Classification of disease was not improved by B-type natriuretic peptide or hs-CRP when added to conventional risk factors, although the latter seems to have value in patients without earlier CVD and low-density lipoprotein-cholesterol of less than 3.4 mmol/l; the adjusted odds ratio for hs-CRP >or=2 mg/l in this sub-group was 2.49 (1.12-5.51, P=0.024). CONCLUSION: Framingham and SCORE risk models can be used in clinical practice to predict angiographic coronary disease although risk factor modification limits the predictive value of smoking, blood pressure, lipid profiles and cardiac biomarkers.
Authors: Zhen Sinead Wang; Jonathan Yap; Yi Ling Eileen Koh; Shaw Yang Chia; N Nivedita; Teck Wee Andrew Ang; Soo Chye Paul Goh; Cia Sin Lee; Lee Lim Joanna Tan; Chai Wah Ooi; Matthew Seow; Khung Keong Yeo; Siang Jin Terrance Chua; Ngiap Chuan Tan Journal: J Gen Intern Med Date: 2021-03-26 Impact factor: 6.473
Authors: Abdel-Ellah Al-Shudifat; Mohammed Azab; Asgeir Johannessen; Amjad Al-Shdaifat; Lana M Agraib; Reema F Tayyem Journal: Ann Saudi Med Date: 2018 Mar-Apr Impact factor: 1.526
Authors: Dipak Kotecha; Marcus D Flather; Dan Atar; Peter Collins; John Pepper; Elizabeth Jenkins; Christopher M Reid; David Eccleston Journal: BMC Med Date: 2019-04-03 Impact factor: 8.775